This announcement is a separate document:
迈普医学:关于广州迈普再生医学科技股份有限公司2023年年度股东大会的法律意见书
Medprin Regenerative Medical Technologies: Legal Opinion on the 2023 Annual General Meeting of Shareholders of Guangzhou Maipu Regenerative Medicine Technology Co., Ltd.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.